What If the First Antidepressant Doesn't Work? You have more options than you think.

Short answer: roughly one in three people reach full remission on their first antidepressant. That means most people do not, and it is an expected part of the process rather than a sign that treatment has failed. The largest study of this question found that when people kept going through additional steps, about two in three eventually reached remission. The first medication is a starting point, not a verdict.

If you are six or eight weeks in and still waiting to feel like yourself, that is a discouraging place to be. It is also an extremely common place to be. Here is what actually happens next.

First, Three Questions Before Anyone Changes Anything

Before switching medications, a good prescriber checks whether the first one truly got a fair trial. Surprisingly often, it did not:

• Was the dose high enough? Many people are started at a low dose to limit side effects and then never moved up. A starting dose is frequently below the dose that actually treats depression. Staying at 10 mg when the therapeutic range runs higher is not a failed medication, it is an incomplete trial.
• Was it long enough? Antidepressants need 4 to 6 weeks at an adequate dose before you can judge them, and 8 weeks for a full read. Sleep and energy often improve first. Mood and interest are usually the last to lift.
• Is the diagnosis complete? Depression that will not respond sometimes turns out to be bipolar depression, an untreated thyroid problem, sleep apnea, significant alcohol use, ADHD, or grief. Each of these changes the treatment entirely. This is worth revisiting honestly rather than adding a second medication on top of a wrong target.

What "It Didn't Work" Usually Means

These three situations look similar from the inside but lead to different decisions:

• No response at all. Eight weeks at a solid dose and essentially nothing has shifted. This generally points toward switching rather than adjusting.
• Partial response. You are meaningfully better than you were but not well. Maybe 40 or 50 percent improved. This is the most common outcome, and it usually points toward raising the dose or adding something rather than abandoning a medication that is clearly doing something.
• Intolerable side effects. The medication may be working, but the nausea, sexual side effects, sedation, or agitation are not livable. This points toward switching to a different medication with a different side effect profile, not toward giving up on medication as a category.

Telling your prescriber which of these three describes you is the single most useful thing you can do in that appointment.

The Four Moves Available Next

1. Optimize the dose

Raise the current medication to a full therapeutic dose and give it several more weeks. This is often the first move for a partial response, and it is the least disruptive one. No washout, no restarting the clock from zero.

2. Switch within the same class

Moving from one SSRI to another SSRI, for example from sertraline to escitalopram. People respond differently to medications in the same family, so this is a real option and not a technicality. This is often the choice when side effects, rather than lack of effect, were the problem.

3. Switch to a different class

Moving to an SNRI, bupropion, or mirtazapine. These work through different mechanisms and have distinctly different side effect profiles. Bupropion, for instance, tends not to cause sexual side effects or weight gain, which matters a great deal to some people.

4. Augment

Keeping the current medication and adding a second one that boosts it. Common augmentation strategies include adding bupropion to an SSRI, or adding a low dose of an atypical antipsychotic such as aripiprazole. Augmentation is usually preferred when you have had a genuine partial response and do not want to lose the ground you have gained.

What the Research Actually Shows

The STAR*D trial, published in 2006, remains the largest real-world study of what happens when antidepressants do not work the first time. More than 2,800 adults with major depression went through up to four treatment steps. The findings that matter most to patients:

• About 33 percent reached remission on the first medication
• Roughly another 25 percent reached remission at the second step
• Cumulatively, about 67 percent reached remission after up to four steps
• Each additional step had a somewhat lower success rate and a higher relapse rate, which is why getting the early steps right matters

The honest reading of that data is twofold. Persistence pays off substantially. And the odds are best in the first two or three attempts, which is an argument for adequate doses and adequate trial lengths rather than rushed switching.

How Long Each Step Takes

People are often surprised by the timeline, so it helps to know it in advance:

• Dose increase: allow 2 to 4 weeks at the new dose to judge it
• Switch within class: often a cross-taper over 1 to 2 weeks, then 4 to 6 weeks at the target dose
• Switch across class: similar, though some combinations require a washout period for safety
• Augmentation: effects from an added medication are sometimes visible faster, within 1 to 3 weeks

Realistically, working through two or three adjustments takes several months. That is frustrating, and it is also normal. It is not a sign that anything is going wrong.

What You Can Do to Make the Next Trial Count

• Track something simple. A daily 0 to 10 rating of mood, energy, and sleep in your phone notes gives your prescriber far better information than trying to remember six weeks at once. Memory during depression is biased toward the bad days.
• Report side effects early rather than quietly stopping. Many side effects fade after the first two weeks, and the ones that do not can often be managed with a timing change or a dose adjustment.
• Take it consistently. Missed doses are one of the most common reasons a medication looks ineffective. If you are forgetting, say so plainly. It is a solvable problem.
• Be honest about alcohol and cannabis. Both can blunt antidepressant response substantially. This is clinical information, not a moral question.
• Add therapy if you can. The combination of medication and therapy consistently outperforms either alone for moderate to severe depression.
• Check the basics. Untreated sleep apnea, low thyroid, low iron, and vitamin D deficiency all make depression harder to treat. These are simple labs.

When to Talk About Treatment-Resistant Depression

Depression is generally called treatment resistant after two adequate trials of antidepressants at adequate doses and durations have failed. That label is not a dead end. It opens the door to a different set of options, including augmentation strategies, esketamine, transcranial magnetic stimulation, and other approaches with genuine evidence behind them.

If you have been through two full trials without relief, that is the moment to ask directly: what does the next tier of treatment look like for me?